403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Oncolytics Biotech Inc
(MENAFN- Baystreet) 11:27 AM EST - Oncolytics Biotech Inc: Announced the formation of its Gastrointestinal Tumor Scientific Advisory Board (SAB), a group of leading oncology experts assembled to guide the Company's clinical and regulatory strategy for developing pelareorep as a treatment for GI cancers. Oncolytics Biotech Inc
shares N are trading off $0.10 at $0.99.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment